AngioDynamics, Inc.
ANGO · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3.8% | -10.3% | 7.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 53.9% | 50.9% | 51.4% | 52.4% |
| EBITDA | $0 | -$0 | $0 | $0 |
| % Margin | 0.6% | -2% | 3.6% | 3.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -11.6% | -60.7% | -15.5% | -8.4% |
| EPS Diluted | -0.83 | -4.59 | -1.33 | -0.68 |
| % Growth | 81.9% | -245.1% | -95.6% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |